Seòmar agus comataidhean

The treatment of coronary heart disease is a continuously advancing field. Our CHD and Stroke Strategy, which we will publish shortly, will set out arrangements designed to make sure that people in Scotland who suffer from CHD can benefit at as early a stage as possible from those advances.

Record sums are being invested in the NHS by the Scottish Executive so that we can revitalise services for patients everywhere. As part of our action on workforce development we are encouraging innovative multi-professional teamworking, and seeking to reward staff appropriately to the level of responsibility carried. We are working at local, regional and national levels to provide attractive career opportunities for staff at all levels and in all specialities.

The Spending Review 2002 settlement reflects the Care Development Group's costing assumptions for free personal care. These assumptions estimated an increase in demand from unmet need and a shift from informal to formal care of approximately 12% building up over the first two years of the policy to 2004-05. Within that framework, identification of individuals in need of care is a matter for local authorities. The Scottish Executive has provided the necessary resources.

Following the changes introduced to the Capital Planning and Approval processes in April this year, it is anticipated that the majority of the £750 million will be allocated directly to NHS boards to undertake those improvements already under way or planned as part of the board's Capital Investment Programme.Those building projects currently under development include the provision of appropriate facilities for mental health; ambulatory care and diagnostic facilities; reconfiguration of services arising from completed or on-going acute services reviews; improved primary care and community hospital facilities, and investment in and the upgrading of medical equipment. IT projects costing under £1 million are managed under delegated authority by the NHS boards and trusts. Projects managed by NHS boards and trusts costing over £1 million are subject to business case approval by the Health Department. These projects are likely to include the development of electronic integrated care records and systems supporting accident and emergency and ambulatory care and diagnostic services. Such investments will be directed in line with the national Information Management and Technology (IM&T) strategy and the health board IM&T Action Plans currently under development.

This investment will enable 1,000 additional people to move from hospital into more appropriate community-based settings at varying costs. It will also allow local authority and NHS board partnerships to put in place a variety of other measures to tackle delayed discharge, including admissions avoidance and rapid response.

The Food Standards Agency have advised me that they are committed to reducing food-borne illness in Scotland by at least 20%, by 2006.The funding allocated to reduce food-borne illness across the spending review period is:

2003-04	£1.4 million
2004-05	£4.1 million
2005-06	£3.9 million

The terms in-patient, day case and out-patient denote the type and level of resource used to treat a patient during a particular contact with hospital services. These terms are formally defined by ISD Scotland in its Definitions and Codes manual, which can be accessed at the following web address. Other defined terms include day patients, ward attenders, accident and emergency attenders and nurse only clinic attendances.http://www.show.scot.nhs.uk/isd/isd_services/NHSiS_services/National_data_standards/defsmanual.htm.

Detailed decisions have not yet been made on the distribution of the health budget announced on 12 September.

The national clinical effectiveness organisations, for example the Health Technology Board Scotland, the Scottish Inter-Collegiate Guidelines Network and the Clinical Standards Board for Scotland, are funded to evaluate the clinical and cost effectiveness of health technologies and develop evidence-based clinical guidelines and standards. NHSScotland is expected to take account of advice and evidence from these organisations so that effective medical advances are quickly adopted as mainstream practice across Scotland. NHS boards are expected to allocate their funds so as to meet national and local priorities, including taking account of clinical advances where relevant. NHS boards' allocations for future years will be announced around the turn of the year, and we expect those to be sufficient to meet pay and price increases and clinical advances.

The Health Technology Board for Scotland provides timely advice on the clinical and cost effectiveness of the broad range of existing and new health technologies to NHSScotland, including most recently for mental health on:the prescription of anti-cholinesterases to people with Alzheimer's Disease, andthe prescription of atypical anti-psychotics to people with schizophrenia.NHS Scotland and their care partners will also continue to invest in treatments, approaches, services, support and other interventions that aim not only to treat but also to prevent or reduce the incidence and individual severity of mental illness in Scotland. In terms of investment, over £600 million spent last year alone offers a clear signal of the priority we attach to and our national programme to improve mental health and well-being further signals our intent to maintain this profile.